Home > Term: di-dgA-RFB4
di-dgA-RFB4
An anticancer drug that is a combination of a monoclonal antibody (RFB4) and an immunotoxin (dgA).
- Del af tale: noun
- Branche/domæne: Health care
- Category: Cancer treatment
- Company: U.S. HHS
0
Ophavsmand
- Lionel M
- 100% positive feedback